Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-021252
Filing Date
2017-08-30
Accepted
2017-08-30 16:05:35
Documents
1
Period of Report
2017-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3733
  Complete submission text file 0000899243-17-021252.txt   5219
Mailing Address 200 SIDNEY STREET SUITE 320 CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET SUITE 320 CAMBRIDGE MA 02139 617-401-9975
SYNLOGIC, INC. (Issuer) CIK: 0001527599 (see all company filings)

EIN.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ORBIMED ADVISORS 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Khuong Chau Quang (Reporting) CIK: 0001609405 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37566 | Film No.: 171060747